Zenith Drugs wins Rs 3.93 crore Karnataka tender

1 min read     Updated on 26 May 2026, 03:09 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Zenith Drugs Limited secured a Rs 3.93 Crore tender from Karnataka State Medical Supplies Corporation Limited for supplying Oral Rehydration Salts. The order covers 16,388,432 units and strengthens the company's institutional business presence. The disclosure was made under Regulation 30 of SEBI LODR Regulations, 2015.

powered bylight_fuzz_icon
41290784

*this image is generated using AI for illustrative purposes only.

Zenith Drugs Limited has secured a significant order worth Rs 3.93 Crore from Karnataka State Medical Supplies Corporation Limited to supply pharmaceutical products. The contract, awarded in the normal course of business, involves the supply of Oral Rehydration Salts IP 20.5 gm (1x1 sachet). This development reinforces the company's presence in the institutional pharmaceutical supply segment and underscores the confidence of government healthcare agencies in its product quality and execution capabilities.

The order details were disclosed to the National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that this transaction does not fall under related party transactions. Execution of this order is anticipated to enhance the company's revenue visibility and deepen its engagement with public healthcare institutions.

Order Details

Parameter Details
Name of Authority Karnataka State Medical Supplies Corporation Limited
Nature of Contract Supply of pharmaceutical product
Product Oral Rehydration Salts IP 20.5 gm (1x1 sachet)
Quantity 16388432
Order Value approx. Rs. 3.93 Crore

The communication was addressed to the Listing Compliance Department of the exchange and signed by Sakshi Bhawsar, Company Secretary & Compliance Officer of Zenith Drugs Limited.

Historical Stock Returns for Zenith Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
-2.15%+16.54%+5.09%-15.83%-40.97%-56.78%

What is the expected timeline for the execution and delivery of this order?

Could this success with Karnataka State Medical Supplies Corporation lead to similar contracts from other state government agencies?

How will this order impact Zenith Drugs' revenue projections for the current fiscal year?

Zenith Drugs Limited Awarded Tender by Madhya Pradesh Public Health Services Corporation

1 min read     Updated on 06 May 2026, 09:44 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Zenith Drugs Limited secured a Rs. 45,63,145 order from Madhya Pradesh Public Health Services Corporation for supplying 5,14,447 tubes of Mupirocin Ointment. The contract, awarded on May 05, 2026, is not a related party transaction and is expected to enhance operational performance.

powered bylight_fuzz_icon
39586473

*this image is generated using AI for illustrative purposes only.

zenith drugs has been awarded a significant tender by the Madhya Pradesh Public Health Services Corporation Limited. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This order is viewed as a meaningful addition to the company's order book and reinforces its growing presence in the domestic pharmaceutical supply segment.

Contract Details

The contract pertains to the supply of a specific pharmaceutical product. The company has confirmed that this order has been awarded in the normal course of business and does not fall under related party transactions. Zenith Drugs remains committed to the timely execution of the order while maintaining high standards of quality and compliance.

Order Specifications

The specific details regarding the product and the financial value of the tender are outlined below:

Specification Details
Name of Entity Madhya Pradesh Public Health Services Corporation Limited
Nature of Contract Supply of Pharmaceutical Product
Product Mupirocin Ointment (2% w/w, 5 gm tube)
Approximate Quantity 5,14,447 tubes
Total Order Value Rs. 45,63,145/-

Strategic Impact

Management believes that this development will further strengthen the company's operational performance. The successful bid is expected to contribute positively to stakeholder value over the coming periods. The intimation was submitted to the National Stock Exchange of India Limited on May 05, 2026.

Historical Stock Returns for Zenith Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
-2.15%+16.54%+5.09%-15.83%-40.97%-56.78%

How might Zenith Drugs leverage this government tender win to pursue larger state and central procurement contracts in the antibiotics and topical medications segment?

What impact could a sustained increase in government health procurement orders have on Zenith Drugs' revenue mix and profit margins over the next few fiscal years?

Could growing demand for generic topical antibiotics like Mupirocin from public health bodies signal broader opportunities for small-cap pharma companies in India's government procurement ecosystem?

More News on Zenith Drugs

1 Year Returns:-40.97%